Vitamin E secretion by Caco-2 monolayers to APOA1, but not to HDL, is vitamer selective.
The aim of this study was to characterize the pathways of basolateral secretion of common dietary tocopherols from polarized Caco-2 monolayers, a model of intestinal absorption. Given differences in structure and physical properties, we hypothesized that secretion may differ between different forms of vitamin E, thus potentially contribute to the selectivity seen in vivo. Monolayers were incubated apically and simultaneously with 10 μmol/L α-, γ-, and δ-tocopherol (1:1:1) in lipid micelles. Treatment with the microsomal triglyceride transfer protein inhibitor BMS201038 revealed that the triglyceride-rich particle secretory pathway (apolipoprotein B-dependent pathway) accounted for ~ 80% of total tocopherol secretion, without selectivity among the three forms of vitamin E. Apolipoprotein B-independent secretion of tocopherols (and cholesterol) was greatly enhanced by the liver X receptor agonist T0901317. T0901317 induced ATP-binding cassette transporter A1 (ABCA1) protein expression and basolateral secretion of tocopherols to apolipoprotein A1. ABCA1-dependent secretion demonstrated vitamer selectivity such that efficiency of secretion of α- and γ-tocopherols exceeded that of δ-tocopherol. Basal addition of HDL stimulated vitamin E secretion but without selectivity among the three forms, whereas LDL had no effect. Basal addition of scavenger receptor class B member I (SR-BI) blocking antibody, which inhibits the interaction between SR-BI and HDL, increased basal accumulation of all tocopherols, demonstrating a role for SR-BI in cellular re-uptake of secreted vitamin E. These findings demonstrated that vitamin E and cholesterol utilize common pathways of secretion and that secretion via the ABCA1 pathway favors certain forms of vitamin E.
Division of Nutritional Sciences, Cornell University, Ithaca, NY.
Nathalie
N
Nicod
Robert S
RS
Parker
D018528:ATP-Binding Cassette Transporters / Q000378:metabolism*; D000924:Anticholesteremic Agents / Q000494:pharmacology; D016632:Apolipoprotein A-I / Q000378:metabolism*; D001562:Benzimidazoles / Q000494:pharmacology; D018938:Caco-2 Cells; D002352:Carrier Proteins / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism*; D000071518:Liver X Receptors; D008823:Micelles; D008954:Models, Biological; D057093:Orphan Nuclear Receptors / Q000378:metabolism; D051122:Scavenger Receptors, Class B / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D024505:Tocopherols / Q000378:metabolism*; D014810:Vitamin E / Q000378:metabolism*; D005466:Fluorocarbons; D000096926:Benzenesulfonamides
D018528:ATP-Binding Cassette Transporters; D000924:Anticholesteremic Agents; D016632:Apolipoprotein A-I; D001562:Benzimidazoles; D002352:Carrier Proteins; D002784:Cholesterol; D006845:Hydrocarbons, Fluorinated; D008075:Lipoproteins, HDL; D000071518:Liver X Receptors; D008823:Micelles; D057093:Orphan Nuclear Receptors; D051122:Scavenger Receptors, Class B; D013449:Sulfonamides; D024505:Tocopherols; D014810:Vitamin E; C473731:BMS201038; C423915:T0901317; D005466:Fluorocarbons; D000096926:Benzenesulfonamides; C106092:microsomal triglyceride transfer protein